Related Experiment Video
Updated: Jul 5, 2026
05:47
Animal Models of Depression - Chronic Despair Model (CDM)
Published on: September 23, 2021
Galanin, galanin receptor subtypes and depression-like behaviour
E Kuteeva1, T Hökfelt, T Wardi
1Department of Neuroscience, Karolinska Institutet, Retzius väg. 8, S-17177 Stockholm, Sweden.
Cellular and Molecular Life Sciences : CMLS
|May 27, 2008
Summary
Galanin, a neuropeptide, influences depression-like behaviors by interacting with specific receptors. Targeting galanin receptors, particularly GalR2, may offer new avenues for developing effective antidepressant treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Depression pathophysiology involves unclear monoaminergic transmission disturbances.
- Current antidepressants have limited efficacy and side effects.
- Neuropeptides like galanin are increasingly implicated in mood disorders.
Purpose of the Study:
- To investigate the role of galanin and its receptor subtypes in depression.
- To explore galanin receptor subtypes as potential therapeutic targets for novel antidepressants.
Main Methods:
- Review of pharmacological and genetic studies on galanin in depression-like behavior in rodents.
- Analysis of galanin's coexpression and modulation of noradrenaline and serotonin systems.
Main Results:
- Galanin modulates noradrenaline and serotonin systems implicated in depression.
- Stimulation of Galanin Receptor 1 (GalR1) and/or Galanin Receptor 3 (GalR3) leads to depression-like phenotypes.
- Activation of Galanin Receptor 2 (GalR2) attenuates depression-like behavior.
Conclusions:
- Galanin receptor subtypes play a significant role in depression-like behaviors.
- Targeting specific galanin receptor subtypes, especially GalR2, holds promise for developing novel antidepressant therapies.
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...